Dr Dannel Yeo is an emerging expert in translational cancer research and precision medicine who leads the Precision Oncology Laboratory at Centenary Institute.. He has led efforts to understand cancer drivers in patients to identify effective therapies using patient-derived organoids and liquid biopsies. He is a Sydney Cancer Partners Translational Partners Fellow and has secured competitive grants from Tour de Cure, PanKind, Sydney Cancer Institute as well as several philanthropic grants. He holds affiliations as an Honorary Lecturer at the University of Sydney and Honorary Research Scientist at the Royal Prince Alfred Hospital.
He completed his PhD in cancer cell biology from the University of Melbourne (2017), focusing on preclinical mouse models in pancreatic cancer. Following this, he established patient-derived organoids during his postdoctoral position at the University of Melbourne Centre for Cancer Research. He joined the Gene and Stem Cell Therapy Program at the Centenary Institute in 2019 as a postdoctoral researcher where he worked on cellular immunotherapy (CAR-T cell therapy) in pancreatic cancer. He is the secretary of the Centenary Institute Postdoc Association and is the EMCR member on the Sydney Cancer Partners Steering Committee.
